A 3-Month Non-Interventional Study of Asthmatics Treatment With Symbicort® Turbuhaler®

Safety & Efficacy of Symbicort® Turbuhaler® (1, 2, and 4 x 160/4.5 µg Twice Daily) in Japanese Patients With Asthma

NCT00255255 ·Status: COMPLETED ·Phase: PHASE3

Study to Investigate Real Life Effectiveness of Symbicort Maintenance and Reliever Therapy in Asthma Patients Across Asia

NCT00939341 ·Status: COMPLETED ·Phase: PHASE4

Symbicort SMART (Symbicort Maintenance And Reliever Therapy)

NCT00523679 ·Status: COMPLETED

Symbicort Turbuhaler 30/60 Clinical Experience Investigation

NCT01232348 ·Status: COMPLETED

STYLE - Symbicort Single Inhaler Therapy vs Conventional Therapy in Treatment of Persistent Asthma

NCT00252824 ·Status: COMPLETED ·Phase: PHASE3

Symbicort Maintenance and Reliever Therapy - Experience in Real Life Setting in Malaysia

NCT00576316 ·Status: COMPLETED ·Phase: PHASE4

Symbicort Single Inhaler Therapy vs Conventional Best Practice for the Treatment of Persistent Asthma in Adults

NCT00385593 ·Status: TERMINATED ·Phase: PHASE3

Real Life Effectiveness in Asthma of Symbicort Single Inhaler Therapy

NCT00319306 ·Status: COMPLETED ·Phase: PHASE3

A Follow-up Programme for Patients Using Symbicort SMART in Normal Clinical Practice

NCT00505388 ·Status: COMPLETED

Efficacy of Symbicort pMDI Administered Once Daily in Adolescents and Adults During 12 Weeks - STEM

NCT00652392 ·Status: COMPLETED ·Phase: PHASE3

A Clinical Study to Evaluate Symbicort Turbuhaler Used 'as Needed' in Adults and Adolescents With Asthma.

NCT02149199 ·Status: COMPLETED ·Phase: PHASE3

SYMPHONIE - A Comparison of Symbicort Single Inhaler and Conventional Best Practice for the Treatment of Persistent Asthma in Adolescents and Adults

NCT00259792 ·Status: COMPLETED ·Phase: PHASE3

Physician and Patient Perception of Adjustable Maintenance Dosing of Symbicort Turbuhaler

NCT00812682 ·Status: COMPLETED

SOLO-Symbicort® in the Treatment of Persistent Asthma in Adolescents & Adults

NCT00238784 ·Status: COMPLETED ·Phase: PHASE3

A Pharmaceopidemiological Study in Patients Who Use Symbicort SMART

NCT00503061 ·Status: COMPLETED

A Clinical Study to Evaluate Symbicort Turbuhaler Used 'as Needed' in Adults and Adolescents With Asthma

NCT02224157 ·Status: COMPLETED ·Phase: PHASE3

An Observational, Prospective, Multicenter Study to Evaluate the Biologic Use and Outcomes in Chinese Asthma Patients

NCT06605885 ·Status: ACTIVE_NOT_RECRUITING

DESOLO - SiT Peri-Launch: A Comparison of Symbicort Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma in Adults

NCT00252863 ·Status: COMPLETED ·Phase: PHASE3

CONCEPT: A 1-Year Comparison Of A Stable Dose Of SERETIDE® Inhaler With An Adjustable Maintenance Dose Of SYMBICORT® Inhaler. SERETIDE® Inhaler is a Trademark of GSK Group of Companies. SYMBICORT® Inhaler is a Trademark of Astra Zeneca.

NCT00479739 ·Status: COMPLETED ·Phase: PHASE4

A Comparison of Symbicort® Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma

NCT00628758 ·Status: COMPLETED ·Phase: PHASE3

Symbicort Usage in Asthma Treatment and Impact of a New Therapeutic Strategy on Compliance and Asthma Control in France

NCT00812357 ·Status: COMPLETED

A Study to Evaluate the Effectiveness and Safety of MEDI-528 in Adults

NCT00968669 ·Status: COMPLETED ·Phase: PHASE2

Symbicort Single Inhaler Therapy for Asthma in a General Practice Setting

NCT00235911 ·Status: COMPLETED ·Phase: PHASE3

A Study of CM310 in Subjects With Moderate to Severe Asthma

NCT05761028 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

A Translational Study to Describe Clinical Characteristics, Biomarkers and to Identify Phenotypes and Endotypes Associated With Differential Outcomes in Chinese Population

NCT06419413 ·Status: RECRUITING